Cargando…

Roxadustat, a Hypoxia-Inducible Factor 1α Activator, Attenuates Both Long- and Short-Term Alcohol-Induced Alcoholic Liver Disease

Alcoholic liver disease (ALD) is a worldwide healthcare problem featured by inflammation, reactive oxygen species (ROS), and lipid dysregulation. Roxadustat is used for chronic kidney disease anemia treatment. As a specific inhibitor of prolyl hydroxylase, it can maintain high levels of hypoxia-indu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Yongyao, Jiang, Xiaomeng, Yang, Daigang, Guo, Wentong, Wang, Dandan, Gong, Ke, Peng, Ying, Jiang, Hong, Shi, Cunyuan, Duan, Yajun, Chen, Yuanli, Han, Jihong, Yang, Xiaoxiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127324/ https://www.ncbi.nlm.nih.gov/pubmed/35620283 http://dx.doi.org/10.3389/fphar.2022.895710

Ejemplares similares

Hypoxia-inducible factor upregulation by roxadustat attenuates drug reward by altering brain iron homoeostasis
por: Yan, Pengju, et al.
Publicado: (2023)

Roxadustat: Not just for anemia
por: Zhu, Xiaoyu, et al.
Publicado: (2022)

Both Ketamine and NBQX Attenuate Alcohol-Withdrawal Induced Depression in Male Rats
por: Getachew, Bruk, et al.
Publicado: (2019)

Resolution of epoetin‐induced pure red cell aplasia, successful re‐challenge with roxadustat
por: Wu, Yunzhou, et al.
Publicado: (2020)

Combination of Colchicine and Ticagrelor Inhibits Carrageenan-Induced Thrombi in Mice
por: Zhang, BuChun, et al.
Publicado: (2022)

Overexpression of NgBR inhibits high-fat diet–induced atherosclerosis in ApoE-deficiency mice
por: Gong, Ke, et al.
Publicado: (2023)

A Novel Choice to Correct Inflammation-Induced Anemia in CKD: Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat
por: Yan, Zhipeng, et al.
Publicado: (2020)

Cardiovascular Protective Effects of Oral Hypoxia Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat in the Treatment of Type 4 Cardiorenal-Anemia Syndrome: Protocol of a Randomized Controlled Trial
por: Wen, Yumin, et al.
Publicado: (2022)

Effect of Moderate Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Roxadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor
por: Groenendaal-van de Meent, Dorien, et al.
Publicado: (2016)

Effect of Kidney Function and Dialysis on the Pharmacokinetics and Pharmacodynamics of Roxadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor
por: Groenendaal-van de Meent, Dorien, et al.
Publicado: (2020)

Oral Probiotic Expressing Human Ethanol Dehydrogenase Attenuates Damage Caused by Acute Alcohol Consumption in Mice
por: Jiang, Xiaoxiao, et al.
Publicado: (2023)

Roxadustat: Do we know all the answers?
por: Li, Qiu-Yu, et al.
Publicado: (2023)

Roxadustat promotes hypoxia‐inducible factor‐1α/vascular endothelial growth factor signalling to enhance random skin flap survival in rats
por: Lan, Qicheng, et al.
Publicado: (2023)

Clinical Pharmacokinetics and Pharmacodynamics of Roxadustat
por: Czock, David, et al.
Publicado: (2021)

Sleeve gastrectomy attenuates high fat diet-induced non-alcoholic fatty liver disease
por: Pei, Erli, et al.
Publicado: (2018)

Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against renal ischemia/reperfusion injury by inhibiting inflammation
por: Miao, A-Feng, et al.
Publicado: (2021)

Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
por: Holzner, Lorenz M. W., et al.
Publicado: (2021)

Inhibition of high-fat diet–induced obesity via reduction of ER-resident protein Nogo occurs through multiple mechanisms
por: Wang, Xiaolin, et al.
Publicado: (2022)

Roxadustat and thyroid-stimulating hormone suppression
por: Tokuyama, Atsuyuki, et al.
Publicado: (2021)

Roxadustat (FG-4592) Facilitates Recovery From Renal Damage by Ameliorating Mitochondrial Dysfunction Induced by Folic Acid
por: Li, Xue, et al.
Publicado: (2022)

Intermittent Fasting Inhibits High-Fat Diet–Induced Atherosclerosis by Ameliorating Hypercholesterolemia and Reducing Monocyte Chemoattraction
por: Chen, Yuanli, et al.
Publicado: (2021)

LongShengZhi Capsule Attenuates Alzheimer-Like Pathology in APP/PS1 Double Transgenic Mice by Reducing Neuronal Oxidative Stress and Inflammation
por: Yin, Zequn, et al.
Publicado: (2020)

Efficacy of roxadustat in treatment of peritoneal dialysis patients with renal anaemia
por: Zhu, Xin-Wang, et al.
Publicado: (2021)

Alcohol-Induced Glycolytic Shift in Alveolar Macrophages Is Mediated by Hypoxia-Inducible Factor-1 Alpha
por: Morris, Niya L., et al.
Publicado: (2022)

Radioprotective effects of roxadustat (FG‐4592) in haematopoietic system
por: Zhang, Pei, et al.
Publicado: (2018)

Maltol, a Food Flavoring Agent, Attenuates Acute Alcohol-Induced Oxidative Damage in Mice
por: Han, Ye, et al.
Publicado: (2015)

Central administration of the anorexigenic peptide neuromedin U decreases alcohol intake and attenuates alcohol‐induced reward in rodents
por: Vallöf, Daniel, et al.
Publicado: (2016)

Nobiletin Alleviates Astrocyte Activation and Oxidative Stress Induced by Hypoxia In Vitro
por: Wang, Dandan, et al.
Publicado: (2022)

Thyroid function analysis after roxadustat or erythropoietin treatment in patients with renal anemia: a cohort study
por: Zheng, Xiaomeng, et al.
Publicado: (2023)

Probiotics attenuate alcohol-induced muscle mechanical hyperalgesia: Preliminary observations
por: Green, Paul G, et al.
Publicado: (2022)

The association between workload, alcohol use, and alcohol misuse among psychiatrists in China
por: Li, Wenzheng, et al.
Publicado: (2023)

Effects of Roxadustat on Erythropoietin Production in the Rat Body
por: Yasuoka, Yukiko, et al.
Publicado: (2022)

Role of Hypoxia Inducing Factor-1β in Alcohol-Induced Autophagy, Steatosis and Liver Injury in Mice
por: Ni, Hong-Min, et al.
Publicado: (2014)

Alcohol-induced brain deficit in alcohol dependence
por: Wang, Yanping, et al.
Publicado: (2022)

The role of roxadustat in chronic kidney disease patients complicated with anemia
por: Liu, Jie, et al.
Publicado: (2023)

Activation of liver X receptor inhibits the development of pulmonary carcinomas induced by 3-methylcholanthrene and butylated hydroxytoluene in BALB/c mice
por: Wang, Qixue, et al.
Publicado: (2016)

Betaine attenuates chronic alcohol-induced fatty liver by broadly regulating hepatic lipid metabolism
por: Yang, Wenjuan, et al.
Publicado: (2017)

MEK1/2 inhibitor inhibits neointima formation by activating miR-126-3p/ C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 4 (CXCR4) axis
por: Yan, Yali, et al.
Publicado: (2022)

Roxadustat Attenuates the Disruption of Epithelial Tight Junction in Caco2 Cells and a Rat Model of CKD Through MicroRNA-223
por: Qu, Ning, et al.
Publicado: (2022)

Procyanidin B2 Reduces Vascular Calcification through Inactivation of ERK1/2-RUNX2 Pathway
por: Liang, Yingquan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lsj4e33gc7t4ii7arld4isf265